192 related articles for article (PubMed ID: 30515563)
1. Pancreatic cancer arising from the remnant pancreas after pancreatectomy: a multicenter retrospective study by the Kyushu Study Group of Clinical Cancer.
Hashimoto D; Arima K; Nakagawa S; Negoro Y; Hirata T; Hirota M; Inomata M; Fukuzawa K; Ohga T; Saeki H; Oki E; Yamashita YI; Chikamoto A; Baba H; Maehara Y
J Gastroenterol; 2019 May; 54(5):437-448. PubMed ID: 30515563
[TBL] [Abstract][Full Text] [Related]
2. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M
Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
[TBL] [Abstract][Full Text] [Related]
3. Resection for recurrent pancreatic cancer in the remnant pancreas after pancreatectomy is clinically promising: Results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Yamada S; Kobayashi A; Nakamori S; Baba H; Yamamoto M; Yamaue H; Fujii T
Surgery; 2018 Nov; 164(5):1049-1056. PubMed ID: 30068484
[TBL] [Abstract][Full Text] [Related]
4. Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile?
Miyazaki M; Yoshitomi H; Shimizu H; Ohtsuka M; Yoshidome H; Furukawa K; Takayasiki T; Kuboki S; Okamura D; Suzuki D; Nakajima M
Surgery; 2014 Jan; 155(1):58-66. PubMed ID: 24238124
[TBL] [Abstract][Full Text] [Related]
5. Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy.
Ishida J; Toyama H; Matsumoto I; Asari S; Goto T; Terai S; Nanno Y; Yamashita A; Mizumoto T; Ueda Y; Kido M; Ajiki T; Fukumoto T; Ku Y
Pancreatology; 2016; 16(4):615-20. PubMed ID: 27237099
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer in the remnant pancreas following primary pancreatic resection.
Hashimoto D; Chikamoto A; Ohmuraya M; Sakata K; Miyake K; Kuroki H; Watanabe M; Beppu T; Hirota M; Baba H
Surg Today; 2014 Jul; 44(7):1313-20. PubMed ID: 23975591
[TBL] [Abstract][Full Text] [Related]
7. [An Evaluation of Outcome of Surgical Treatment for Recurrence after Curative Pancreatectomy for Pancreatic Ductal Cancer].
Miyamoto A; Maeda S; Hama N; Haraguchi N; Yamamoto K; Miyake M; Nishikawa K; Omiya H; Miyazaki M; Ikeda M; Hirao M; Takami K; Sekimoto M; Nakamori S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1454-6. PubMed ID: 26805061
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of completion pancreatectomy for recurrence of adenocarcinoma in the remnant pancreas.
Nakayama Y; Sugimoto M; Gotohda N; Konishi M; Takahashi S
J Surg Res; 2018 Jan; 221():15-23. PubMed ID: 29229121
[TBL] [Abstract][Full Text] [Related]
9. Genetic assessment of recurrent pancreatic high-risk lesions in the remnant pancreas: Metachronous multifocal lesion or local recurrence?
Gotoh Y; Ohtsuka T; Nakamura S; Shindo K; Ohuchida K; Miyasaka Y; Mori Y; Mochidome N; Oda Y; Nakamura M
Surgery; 2019 Apr; 165(4):767-774. PubMed ID: 30497813
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Cancer Arising From the Remnant Pancreas: Is It a Local Recurrence or New Primary Lesion?
Hashimoto D; Chikamoto A; Masuda T; Nakagawa S; Imai K; Yamashita YI; Reber HA; Baba H
Pancreas; 2017 Oct; 46(9):1083-1090. PubMed ID: 28902776
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary.
Luchini C; Pea A; Yu J; He J; Salvia R; Riva G; Weiss MJ; Bassi C; Cameron JL; Hruban RH; Goggins M; Wolfgang CL; Scarpa A; Wood LD; Lawlor RT
Mod Pathol; 2019 May; 32(5):659-665. PubMed ID: 30467323
[TBL] [Abstract][Full Text] [Related]
12. Resectable carcinoma developing in the remnant pancreas 7 years and 10 months after distal pancreatectomy for invasive ductal carcinoma of the pancreas: report of a case.
Akabori H; Shiomi H; Naka S; Murakami K; Murata S; Ishida M; Kurumi Y; Tani T
World J Surg Oncol; 2014 Jul; 12():224. PubMed ID: 25034035
[TBL] [Abstract][Full Text] [Related]
13. Total pancreatectomy for metachronous mixed acinar-ductal carcinoma in a remnant pancreas.
Shonaka T; Inagaki M; Akabane H; Yanagida N; Shomura H; Yanagawa N; Oikawa K; Nakano S
World J Gastroenterol; 2014 Sep; 20(33):11904-9. PubMed ID: 25206298
[TBL] [Abstract][Full Text] [Related]
14. Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer.
Haas M; Ormanns S; Baechmann S; Remold A; Kruger S; Westphalen CB; Siveke JT; Wenzel P; Schlitter AM; Esposito I; Quietzsch D; Clemens MR; Kettner E; Laubender RP; Jung A; Kirchner T; Boeck S; Heinemann V
Br J Cancer; 2017 May; 116(11):1462-1469. PubMed ID: 28449008
[TBL] [Abstract][Full Text] [Related]
15. Metachronous multiple adenocarcinomas of the pancreas.
Ikematsu Y; Tamura H; Nakata Y; Hayashi T; Kanai T; Hirayama K; Mori H; Ozawa T; Hasegawa S; Okawada T; Kageyama S; Sugimura H; Nishiwaki Y
Int J Clin Oncol; 2011 Dec; 16(6):726-31. PubMed ID: 21365362
[TBL] [Abstract][Full Text] [Related]
16. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas.
Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
Surgery; 2016 Aug; 160(2):306-17. PubMed ID: 27236360
[TBL] [Abstract][Full Text] [Related]
17. Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP).
Fensterer H; Schade-Brittinger C; Müller HH; Tebbe S; Fass J; Lindig U; Settmacher U; Schmidt WE; Märten A; Ebert MP; Kornmann M; Hofheinz R; Endlicher E; Brendel C; Barth PJ; Bartsch DK; Michl P; Gress TM;
Ann Oncol; 2013 Oct; 24(10):2576-2581. PubMed ID: 23897705
[TBL] [Abstract][Full Text] [Related]
18. Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research.
Baechmann S; Ormanns S; Haas M; Kruger S; Remold A; Modest DP; Kirchner T; Jung A; Werner J; Heinemann V; Boeck S
BMC Cancer; 2017 May; 17(1):374. PubMed ID: 28549417
[TBL] [Abstract][Full Text] [Related]
19. Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients.
Miyazawa M; Katsuda M; Maguchi H; Katanuma A; Ishii H; Ozaka M; Yamao K; Imaoka H; Kawai M; Hirono S; Okada KI; Yamaue H
Int J Cancer; 2017 Feb; 140(4):973-982. PubMed ID: 27861852
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcome of Resected Remnant Pancreatic Cancer After Resection of the Primary Pancreatic Cancer.
Suzuki S; Shimoda M; Shimazaki J; Maruyama T; Nishida K
J Invest Surg; 2019 Nov; 32(7):670-678. PubMed ID: 29589962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
